Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (111-120 of 573) with videos related to

Pageof 58
Sort By:
Bone Marrow Transplantation|January 1, 1994
Clonality studies in CML patients treated by IFN and/or autologous bone marrow transplantationF Lo Coco, A Guerrasio, D Diverio, et al.
Haematologica|March 1, 1992
Ascorbic acid for the treatment of autoimmune thrombocytopenic purpuraA Chistolini, G Mazzucconi, V De Sanctis, et al.
Haematologica|May 1, 1990
Post-remission treatment in acute myeloid leukemia: chemotherapy or autologous or allogeneic bone marrow transplantationF Mandelli, J K Rees, N C Gorin, et al.
Recenti Progressi in Medicina|September 1, 1993
[Good health. The results of a study (II)]P Conforti, A Cajozzo, F Mandelli, et al.
Journal of Internal Medicine|December 1, 1989
Waldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patientsM T Petrucci, G Avvisati, M Tribalto, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Clinical applications of autologous bone marrow transplants. Results in leukemia]F Mandelli, G Meloni, P De Fabritiis, et al.
The American Journal of the Medical Sciences|May 1, 1984
Cotrimoxazole prophylaxis in patients with leukemia and prolonged granulocytopeniaP Martino, M Venditti, M C Petti, et al.
European Journal of Haematology|January 1, 1991
Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL)F Mandelli, R Gastaldi, B Monarca, et al.
Bone Marrow Transplantation|July 1, 1990
Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocolR Zittoun, F Mandelli, T De Witte, et al.
Recenti Progressi in Medicina|July 1, 1971
[Hemorrhagic disease caused by factor V deficiency (parahemophilia)]F Mandelli, G M Gandolfo, G Isacchi, et al.
Pageof 58

Showing results (111-120 of 573) with videos related to

Sort By:
Pageof 58
Bone Marrow Transplantation|January 1, 1994
Clonality studies in CML patients treated by IFN and/or autologous bone marrow transplantationF Lo Coco, A Guerrasio, D Diverio, et al.
Haematologica|March 1, 1992
Ascorbic acid for the treatment of autoimmune thrombocytopenic purpuraA Chistolini, G Mazzucconi, V De Sanctis, et al.
Haematologica|May 1, 1990
Post-remission treatment in acute myeloid leukemia: chemotherapy or autologous or allogeneic bone marrow transplantationF Mandelli, J K Rees, N C Gorin, et al.
Recenti Progressi in Medicina|September 1, 1993
[Good health. The results of a study (II)]P Conforti, A Cajozzo, F Mandelli, et al.
Journal of Internal Medicine|December 1, 1989
Waldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patientsM T Petrucci, G Avvisati, M Tribalto, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Clinical applications of autologous bone marrow transplants. Results in leukemia]F Mandelli, G Meloni, P De Fabritiis, et al.
The American Journal of the Medical Sciences|May 1, 1984
Cotrimoxazole prophylaxis in patients with leukemia and prolonged granulocytopeniaP Martino, M Venditti, M C Petti, et al.
European Journal of Haematology|January 1, 1991
Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL)F Mandelli, R Gastaldi, B Monarca, et al.
Bone Marrow Transplantation|July 1, 1990
Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocolR Zittoun, F Mandelli, T De Witte, et al.
Recenti Progressi in Medicina|July 1, 1971
[Hemorrhagic disease caused by factor V deficiency (parahemophilia)]F Mandelli, G M Gandolfo, G Isacchi, et al.
Pageof 58